Detalhe da pesquisa
1.
Randomized placebo-controlled crossover study to assess tolerability and pharmacodynamics of zagociguat, a soluble guanylyl cyclase stimulator, in healthy elderly.
Br J Clin Pharmacol
; 89(12): 3606-3617, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37488930
2.
A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma.
Cancer
; 125(14): 2400-2408, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30951193
3.
Locally acting ACE-083 increases muscle volume in healthy volunteers.
Muscle Nerve
; 57(6): 921-926, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29486514
4.
A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Cancer
; 122(23): 3641-3649, 2016 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27648727
5.
First-in-human trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of zagociguat (CY6463), a CNS-penetrant soluble guanylyl cyclase stimulator.
Clin Transl Sci
; 16(8): 1381-1395, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37118895
6.
Tissue expression patterns identify mouse cilia genes.
Physiol Genomics
; 32(2): 198-206, 2008 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-17971504
7.
Randomized Multicenter Study Comparing Safety and Efficacy of Daptomycin Versus Standard-of-care in Pediatric Patients With Staphylococcal Bacteremia.
Pediatr Infect Dis J
; 37(9): 893-900, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29406465
8.
Daptomycin for Complicated Skin Infections: A Randomized Trial.
Pediatrics
; 139(3)2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28202770
9.
The DART Study: Results from the Dose-Escalation and Expansion Cohorts Evaluating the Combination of Dalantercept plus Axitinib in Advanced Renal Cell Carcinoma.
Clin Cancer Res
; 23(14): 3557-3565, 2017 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28031424